WynnVision LLC

WynnVision LLC is a biomedical company founded in 2016 that specializes in developing rapid, surface-modifying technologies for medical devices. By altering surface chemistry, their proprietary approach aims to kill bacteria on contact and inhibit biofilm formation, addressing significant healthcare challenges such as ventilator-associated pneumonia and catheter-related infections. The company provides a range of research services, including surface characterization, antimicrobial efficacy testing, and biocompatibility assessments, utilizing state-of-the-art equipment to perform evaluations consistent with ASTM guidelines.

These capabilities support the healthcare sector by providing innovative strategies to enhance patient safety and device longevity, specifically targeting infections that are difficult to diagnose and treat. Supported by multiple research grants from the National Institutes of Health and various innovation partnerships, WynnVision focuses on translating scientific research into practical, therapeutic solutions. Their work is central to reducing device-related complications, with ongoing projects aimed at improving the performance of indwelling catheters, endotracheal tubes, and surgical shunts.